行情

NEOS

NEOS

Neos
NASDAQ

实时行情|Nasdaq Last Sale

1.540
-0.020
-1.28%
休市 16:00 11/15 EST
开盘
1.560
昨收
1.560
最高
1.580
最低
1.520
成交量
8.22万
成交额
--
52周最高
3.620
52周最低
1.130
市值
7,658.83万
市盈率(TTM)
-1.7460
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NEOS 新闻

  • Edited Transcript of NEOS earnings conference call or presentation 8-Nov-19 1:30pm GMT
  • Thomson Reuters StreetEvents.1小时前
  • 世界首富易主!比尔·盖茨反超亚马逊CEO贝佐斯登顶
  • 中国新闻网.1小时前
  • 苹果为什么不全面开放NFC?不愿改变Apple Pay现状
  • 新浪科技.2小时前
  • Twitter在2020年美国大选前收紧对政治广告的禁令
  • 新浪科技.3小时前

更多

所属板块

制药
+1.37%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

NEOS 简况

Neos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to develop its product for the treatment of attention deficit hyperactivity disorder (ADHD). Its product candidates are extended-release (XR), medications in patient-friendly, orally disintegrating tablets (ODT) or liquid suspension dosage forms. Its branded product and product candidates incorporate over two of the prescribed medications for the treatment of ADHD, methylphenidate and amphetamine. Its modified-release drug delivery platform has enabled it to create extended-release ODT and liquid suspension dosage forms of the medications. It focuses on developing Adzenys XR-ODT, Cotempla XR-ODT and NT-0201.
展开

Webull提供Neos Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。